시장보고서
상품코드
1751262

창상 실란트 시장 규모, 점유율, 동향 분석 리포트 : 실란트별, 창상 유형별, 최종 용도별, 유통 채널별, 지역별, 부문 예측(2025-2030년)

Wound Sealants Market Size, Share & Trends Analysis Report By Sealants (Non-synthetic, Collagen Based, Synthetic), By Wound Type, By End Use, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

창상 실란트 시장 규모와 동향 :

세계의 창상 실란트 시장 규모는 2024년에 5억 5,213만 달러에 달하며, 2025-2030년에 CAGR 5.63%로 확대할 것으로 예측됩니다. 이 시장의 성장은 인구 고령화와 당뇨병 및 심혈관 질환과 같은 만성질환의 유병률 증가에 힘입어 전 세계 외과수술 건수 증가에 기인합니다.

효율적이고 신뢰할 수 있는 상처 봉합 방법을 필요로 하는 최소침습 수술에 대한 수요가 증가하면서 실란트의 채택이 더욱 증가하고 있습니다. 또한 생체 재료 및 합성 제제의 발전으로 상처 봉합제의 효과, 안전성 및 사용 편의성이 향상되어 전통적 수술 및 최신 수술에서 선호되고 있습니다.

MDPI가 2025년 3월에 발표한 논문에 따르면 당뇨병성 족부 궤양 및 욕창과 같은 만성 상처의 유병률 증가는 향후 수년간 시장 성장을 가속할 것으로 예상되며, 당뇨병성 족부는 당뇨병의 가장 심각하고 도전적인 합병증 중 하나이며, 높은 하지 절단율뿐만 아니라 질병 및 사망률 증가와도 밀접한 관련이 있습니다. 질병 및 사망률 증가와 밀접한 관련이 있습니다. 매년 전 세계에서 약 1,860만 명이 당뇨병성 족부 궤양을 앓고 있으며, 당뇨병 관련 하지 절단의 약 80%를 차지하는 주요 원인입니다. 당뇨병 환자의 최대 25%가 당뇨병성 족부궤양 발병 위험이 있으며, 19%에서 34%는 평생 동안 족부궤양을 경험할 가능성이 있는 것으로 추정됩니다. 또한 미국 의사협회가 2023년 11월에 발표한 연구에 따르면 당뇨병 환자의 약 33.33%가 일생 동안 족부궤양이 발생한다고 합니다. 당뇨병성 족부궤양은 미국에서 매년 약 160만 명에게 영향을 미치고 있습니다. 이러한 요인들은 예측 기간 중 상처 밀봉재에 대한 수요를 촉진할 것으로 예측됩니다.

미용, 성형외과, 부인과를 포함한 외과수술 증가는 향후 수년간 시장 성장을 가속할 것으로 예측됩니다. 상처 실란트는 다양한 외과수술에 널리 사용되고 있습니다.

개선된 생체 재료, 전달 방법 및 기능의 개발을 통한 실란트 기술의 지속적인 혁신은 그 용도를 확장하고 시장 성장을 가속하고 있습니다. 예를 들어 2023년 11월 존슨앤드존슨의 MedTech 기업인 Ethicon은 ETHIZIA의 승인을 발표했습니다. 이 보조 지혈재는 임상적으로 문제가 되는 출혈 상황에서 지속적인 지혈 효과를 발휘하는 것으로 입증된 바 있습니다. 독자적인 합성 고분자 기술을 활용한 에티자 지혈 실링 패치는 양면 모두에서 동등한 지혈 효과를 발휘하도록 설계된 최초이자 유일한 지혈 매트릭스입니다. 또한 최소 침습 수술과 로봇 수술의 발전으로 실란트의 필요성이 더욱 커지고 있습니다. 이러한 수술은 과도한 조직 조작 없이 정확하고 통제된 폐쇄가 필요하기 때문입니다.

또한 상처 실란트를 포함한 첨단 상처 관리 제품의 이점에 대한 의료 전문가와 환자의 인식이 높아짐에 따라 이러한 제품의 채택을 촉진하고 시장 성장을 지원하고 있습니다. 이러한 인식은 교육 캠페인과 그 효과를 입증하는 임상적 증거 및 더 나은 환자 결과를 달성하기 위한 집중적인 노력에 힘입어 더욱 강화되고 있습니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 창상 실란트 시장의 변수, 동향 및 범위

  • 시장 계통 전망
    • 보조 시장 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
    • 시장 기회 분석
    • 시장이 해결해야 할 과제 분석
  • 창상 실란트 시장 분석 툴
    • 업계 분석 - Porter의 산업 분석
    • PESTEL 분석
    • COVID-19의 영향 분석

제4장 창상 실란트 시장 : 실란트별 추정·동향 분석

  • 부문 대시보드
  • 창상 실란트별 시장 : 시란별 트 변동 분석과 시장 점유율, 2024년과 2030년
  • 비합성
  • 콜라겐 기반
  • 합성

제5장 창상 실란트 시장 : 창상 유형별 추정·동향 분석

  • 부문 대시보드
  • 창상 실란트 시장 : 창상 유형별 변동 분석과 시장 점유율, 2024년과 2030년
  • 급성 창상
    • 외과수술/시술
    • 열상과 경도 절상
    • 화상
  • 만성 창상
    • 당뇨병성 족궤양
    • 욕창
    • 정맥성 하지 궤양
    • 기타 만성 창상

제6장 창상 실란트 시장 : 최종 용도별 추정·동향 분석

  • 부문 대시보드
  • 창상 실란트 시장 : 최종 용도별 변동 분석과 시장 점유율, 2024년과 2030년
  • 급성기 병원
  • 외래 수술 센터(ASC)
  • 병원 외래 창상관리 클리닉
  • 재택 헬스케어
  • 숙련 간호 시설(SNF)
  • 의사 오피스
  • 화상 센터
  • 입원 재활 시설(IRF)
  • 장기 급성기 케어 병원(LTACH)
  • 장기 케어(주택형)

제7장 창상 실란트 시장 : 유통 채널별 추정·동향 분석

  • 부문 대시보드
  • 창상 실란트 시장 : 유통 채널별 변동 분석과 시장 점유율, 2024년과 2030년
  • 기관투자가용 판매
  • 소매 판매량

제8장 창상 실란트 시장 : 지역별 추정·동향 분석

  • 지역 전망
  • 창상 실란트 시장 : 지역별 변동 분석과 시장 점유율, 2024년과 2030년
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 한국
    • 호주
    • 태국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 쿠웨이트

제9장 경쟁 구도

  • 시장 참여 기업 분류
  • 주요 기업 개요
    • Terumo Corporation
    • Baxter
    • Advanced Medical Solutions Group plc
    • Johnson &Johnson(Ethicon)
    • BD
    • Integra LifeSciences Corporation
    • Cohera Medical, Inc.
    • LifeBond Ltd.
  • 히트맵 분석/기업 시장 현황 분석
  • 2024년 기업 시장 점유율 예측 분석
  • 기타 주요 시장 기업의 리스트
KSA 25.06.26

Wound Sealants Market Size & Trends:

The global wound sealants market size was valued at USD 552.13 million in 2024 and is expected to expand at a CAGR of 5.63% from 2025 to 2030. The market's growth is attributed to the rising global volume of surgical procedures, fueled by an aging population and the increasing prevalence of chronic conditions such as diabetes and cardiovascular diseases.

The growing demand for minimally invasive surgeries, which require efficient and reliable wound closure methods, further boosts the adoption of sealants. In addition, advancements in biomaterials and synthetic formulations are enhancing wound sealants' effectiveness, safety, and usability, making them a preferred choice in traditional and modern surgical practices.

The rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is anticipated to propel the market growth in the coming years. According to the article published by MDPI, in March 2025, diabetic foot is one of the most serious and challenging complications of diabetes, closely linked to high rates of lower limb amputation, as well as increased illness and mortality. Each year, around 18.6 million people globally are affected by diabetic foot ulcers, which are the leading cause of approximately 80% of diabetes-related lower limb amputations. It is estimated that up to 25% of individuals with diabetes are at risk of developing diabetic foot, and between 19% and 34% may experience foot ulcers at some point in their lifetime. Moreover, according to a study published by the American Medical Association in November 2023, around 33.33% of individuals with diabetes develop a foot ulcer during their lifetime. Diabetic foot ulcers impact about 1.6 million individuals in the U.S. each year. These factors are expected to drive the demand for wound sealants over the forecast period.

The growing number of surgical procedures, including cosmetic, orthopedic, and gynecologic, is anticipated to boost the market growth in the coming years. Wound sealants are widely used in various surgical procedures.

Ongoing innovation in sealant technology, with the development of improved biomaterials, delivery methods, and functionalities, is expanding its applications and driving market growth. For instance, in November 2023, Ethicon, a Johnson & Johnson MedTech company, announced the approval of ETHIZIA. This adjunctive hemostat solution has been clinically proven to achieve sustained hemostasis in challenging bleeding scenarios. Utilizing unique synthetic polymer technology, the ETHIZIA Hemostatic Sealing Patch is the first and only hemostatic matrix designed to provide equally effective hemostatic action on both sides. Furthermore, the trend toward minimally invasive and robotic surgeries has strengthened the need for sealants, as these procedures require precision and controlled closure without excessive tissue manipulation.

Moreover, increasing awareness among healthcare professionals and patients about the advantages of advanced wound care products, including wound sealants, is driving their adoption and supporting market growth. This awareness is being fueled by educational campaigns, clinical evidence showcasing their effectiveness, and a strong focus on achieving better patient outcomes.

Global Wound Sealants Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global wound sealants market report on the basis of sealants, wound type, end use, distribution channel, and region:

  • Sealants Outlook (Revenue, USD Million, 2018 - 2030)
  • Non-Synthetic
  • Collagen Based
  • Synthetic
  • Wound Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Acute Wounds
    • Surgical/ Procedure
    • Obstetrics / Gynecology
    • Colorectal
    • Cardiovascular
    • Bariatric and Upper GI
    • Plastic and Reconstructive Surgery
    • Urology
    • Hepato-pancreato-biliary (HPB)
    • Dermatology
    • Others (ENT, Ortho trauma, Neuro, etc.)
    • Lacerations & Minor Cuts
    • Burns
  • Chronic Wounds
    • Diabetic Foot Ulcers
    • Pressure Ulcers
    • Venous Leg Ulcers
    • Other Chronic Wounds
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Acute Care Hospital
  • Ambulatory Surgery Center (ASC)
  • Hospital Outpatient Wound Care Clinic
  • Home Healthcare
  • Skilled Nursing Facility (SNF)
  • Physician Office
  • Burn Center
  • Inpatient Rehabilitation Facility (IRF)
  • Long-term Acute Care Hospital (LTACH)
  • Long-term Care (residential living setting)
  • Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
  • Institutional Sales
  • Retail Sales
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Kuwait
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Purchased database.
  • 1.5. GVR's internal database
  • 1.6. Secondary sources
  • 1.7. Third Party Perspective
  • 1.8. Primary research
  • 1.9. Details of primary research
  • 1.10. Information or Data Analysis
  • 1.11. Data analysis models
  • 1.12. Market Formulation & Validation
  • 1.13. Model Details
  • 1.14. Commodity flow analysis (Model 1)
  • 1.15. Approach 1: Commodity flow approach
  • 1.16. Volume price analysis (Model 2)
  • 1.17. Approach 2: Volume price analysis
  • 1.18. List of Secondary Sources
  • 1.19. List of Primary Sources
  • 1.20. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Wound Sealants Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of chronic diseases
      • 3.2.1.2. Rising surgical volume worldwide
      • 3.2.1.3. Growing preference for minimally invasive surgeries
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunities Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. Wound Sealants Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape
    • 3.3.3. COVID-19 Impact Analysis
      • 3.3.3.1. Disrupted Breast Pump
      • 3.3.3.2. Obstacles in Breast Pump

Chapter 4. Wound Sealants Market: Sealants Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Wound Sealants Market: Sealants Movement Analysis & Market Share, 2024 & 2030
  • 4.3. Non-Synthetic
    • 4.3.1. Non-Synthetic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Collagen based
    • 4.4.1. Collagen Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Synthetic
    • 4.5.1. Synthetic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Wound Sealants Market: Wound Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Wound Sealants Market: Wound Type Movement Analysis & Market Share, 2024 & 2030
  • 5.3. Acute Wounds
    • 5.3.1. Acute Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Surgical/ Procedure
      • 5.3.2.1. Surgical/ Procedure Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.2. Obstetrics / Gynecology
        • 5.3.2.2.1. Obstetrics / Gynecology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.3. Colorectal
        • 5.3.2.3.1. Colorectal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.4. Cardiovascular
        • 5.3.2.4.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.5. Bariatric and Upper GI
        • 5.3.2.5.1. Bariatric and Upper GI Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.6. Plastic and Reconstructive Surgery
        • 5.3.2.6.1. Plastic and Reconstructive Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.7. Urology
        • 5.3.2.7.1. Urology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.8. Hepatopancreatobiliary (HPB)
        • 5.3.2.8.1. Hepatopancreatobiliary (HPB) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.9. Dermatology
        • 5.3.2.9.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.10. Others (ENT, Ortho trauma, Neuro, etc.)
        • 5.3.2.10.1. Others (ENT, Ortho trauma, Neuro, etc.) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Lacerations & Minor Cuts
      • 5.3.3.1. Lacerations & Minor Cuts Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Burns
      • 5.3.4.1. Burns Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Chronic Wounds
    • 5.4.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Diabetic Foot Ulcers
      • 5.4.2.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Pressure Ulcers
      • 5.4.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Venous Leg Ulcers
      • 5.4.4.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. Other Chronic Wounds
      • 5.4.5.1. Other Chronic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Wound Sealants Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Wound Sealants Market: End Use Movement Analysis & Market Share, 2024 & 2030
  • 6.3. Acute Care Hospital
    • 6.3.1. Acute Care Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Ambulatory Surgery Center (ASC)
    • 6.4.1. Ambulatory Surgery Center (ASC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Hospital Outpatient Wound Care Clinic
    • 6.5.1. Hospital Outpatient Wound Care Clinic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Home Healthcare
    • 6.6.1. Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Skilled Nursing Facility (SNF)
    • 6.7.1. Skilled Nursing Facility (SNF) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Physician Office
    • 6.8.1. Physician Office Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Burn Center
    • 6.9.1. Burn Center Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. Inpatient Rehabilitation Facility (IRF)
    • 6.10.1. Inpatient Rehabilitation Facility (IRF) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.11. Long-term Acute Care Hospital (LTACH)
    • 6.11.1. Long-term Acute Care Hospital (LTACH) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.12. Long-term Care (residential living setting)
    • 6.12.1. Long-term Care (residential living setting) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Wound Sealants Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Wound Sealants Market: Distribution Channel Movement Analysis & Market Share, 2024 & 2030
  • 7.3. Institutional Sales
    • 7.3.1. Institutional Sales Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Retail Sales
    • 7.4.1. Retail Sales Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Wound Sealants Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. Wound Sealants Market: Regional Movement Analysis & Market Share, 2024 & 2030
  • 8.3. North America
    • 8.3.1. North America Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Scenario
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. U.S. Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Scenario
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Canada Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Scenario
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Mexico Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Scenario
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. UK Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Scenario
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Germany Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Scenario
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. France Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Scenario
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Italy Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Scenario
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Spain Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Scenario
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Denmark Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Scenario
      • 8.4.8.4. Reimbursement Scenario
      • 8.4.8.5. Sweden Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Scenario
      • 8.4.9.4. Reimbursement Scenario
      • 8.4.9.5. Norway Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Scenario
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Japan Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Scenario
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. China Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Scenario
      • 8.5.4.4. Reimbursement Scenario
      • 8.5.4.5. India Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Scenario
      • 8.5.5.4. Reimbursement Scenario
      • 8.5.5.5. South Korea Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Scenario
      • 8.5.6.4. Reimbursement Scenario
      • 8.5.6.5. Australia Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Scenario
      • 8.5.7.4. Reimbursement Scenario
      • 8.5.7.5. Thailand Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Scenario
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Brazil Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Scenario
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Argentina Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Middle East & Africa
    • 8.7.1. Middle East & Africa Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Scenario
      • 8.7.2.4. Reimbursement Scenario
      • 8.7.2.5. South Africa Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Scenario
      • 8.7.3.4. Reimbursement Scenario
      • 8.7.3.5. Saudi Arabia Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Scenario
      • 8.7.4.4. Reimbursement Scenario
      • 8.7.4.5. UAE Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Scenario
      • 8.7.5.4. Reimbursement Scenario
      • 8.7.5.5. Kuwait Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. Terumo Corporation
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Product Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Baxter
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Product Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. Advanced Medical Solutions Group plc
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Product Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. Johnson & Johnson (Ethicon)
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Product Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. BD
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Product Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. Integra LifeSciences Corporation
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Product Benchmarking
      • 9.2.6.4. Strategic Initiatives
    • 9.2.7. Cohera Medical, Inc.
      • 9.2.7.1. Company Overview
      • 9.2.7.2. Financial Performance
      • 9.2.7.3. Product Benchmarking
      • 9.2.7.4. Strategic Initiatives
    • 9.2.8. LifeBond Ltd.
      • 9.2.8.1. Company Overview
      • 9.2.8.2. Financial Performance
      • 9.2.8.3. Product Benchmarking
      • 9.2.8.4. Strategic Initiatives
  • 9.3. Heat Map Analysis/ Company Market Position Analysis
  • 9.4. Estimated Company Market Share Analysis, 2024
  • 9.5. List of Other Key Market Players
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제